Thu, November 5, 2020
Wed, November 4, 2020
Tue, November 3, 2020

Andrew Fein Upgraded (SYRS) to Strong Buy and Increased Target to $150 on, Nov 4th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-150-on-nov-4th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Andrew Fein of HC Wainwright & Co., Upgraded "Syros Pharmaceuticals, Inc." (SYRS) to Strong Buy and Increased Target from $110 to $150 on, Nov 4th, 2020.

Andrew, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30